// App-Quantinova.ai

: Heparan sulfate: in vitro and in vivo proof of efficacy of this new therapeutic strategy for halting Alzheimer disease related tauopathies development

Researchers

Presenter

  • Gael Le Douaron

Principal Investigators

  • RRRR

  • Aida Muntsant Soria

  • Yong Li

  • Kithika Ramakrishnan

  • Mohand Ouidir Ouidja

  • Alexandre Fifre

  • Sandrine Chantepie-Laborde

  • Estelle Jospin

  • Xavier Laffray

  • Ivan Ramos

  • David Fernig

  • Lydia Gimenez Llort

  • Dulce Papy-Garcia

Medical Centers

  • Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Crown Street, LiverpoolL69 7ZB, United Kingdom.

  • Translational Behavioral Neuroscience Lab, Institut de Neurociències & Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain

  • Univ Paris Est Creteil, Gly-CRRET (4397), Glycobiology Cell Growth Tissue Repair and Regeneration Research Unit, Créteil, F-94010, France

Locations

  • United Kingdom

  • Spain

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved